Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Background: Brain metastases develop in approximately 10–25% of patients with metastatic breast cancer (MBC) and are associated with a very poor prognosis. Case Report: We report the case of a 40-year-old woman with MBC and associated lung, bone, liver, and brain metastases, who experienced a time to progression of several months with eribulin afte...
Alternative Titles
Full title
Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_karger_primary_489066
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_489066
Other Identifiers
ISSN
0030-2414
E-ISSN
1423-0232
DOI
10.1159/000489066
